AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Food Science Article
PDF (2.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Publishing Language: Chinese | Open Access

Progress in the Study of the Role of Grain Proteins and Peptides in Regulating the Therapeutic Targets for Type 2 Diabetes

Han WANG , Dianzhi HOU, Yongxia FU, Qingyu ZHAO, Qun SHEN ( )
National Center of Technology Innovation (Deep Processing of Highland Barley) in Food Industry, National Engineering Research Center for Fruits and Vegetables Processing, College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China
Show Author Information

Abstract

In recent years, numerous studies have demonstrated that grain proteins and peptides derived from their enzymatic hydrolysis such as dipeptidyl peptidase-4 (DPP-Ⅳ), glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and related enzymes can act on the therapeutic targets for type 2 diabetes mellitus (T2DM) and thereby improve T2DM. This article gives a summary of recent research on the beneficial effect of grain proteins and peptides on T2DM, and discusses future prospects for the application of grain proteins and peptides in T2DM treatment.

CLC number: TS201.4 Document code: A Article ID: 1002-6630(2022)09-0310-07

References

【1】
【1】
 
 
Food Science
Pages 310-316

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
WANG H, HOU D, FU Y, et al. Progress in the Study of the Role of Grain Proteins and Peptides in Regulating the Therapeutic Targets for Type 2 Diabetes. Food Science, 2022, 43(9): 310-316. https://doi.org/10.7506/spkx1002-6630-20210409-111

486

Views

2

Downloads

0

Crossref

2

Scopus

1

CSCD

Received: 09 April 2021
Published: 15 May 2022
© Beijing Academy of Food Sciences 2022.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).